We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Health state utility values of type 2 diabetes mellitus and related complications: a systematic review and meta-regression.
- Authors
Wang, Yubo; Xu, Yueru; Shan, Huiting; Pan, Huimin; Chen, Ji; Yang, Jianhua
- Abstract
Background: This study aimed to synthesize and quantitatively examine Health State Utility Values (HSUVs) for Type 2 Diabetes Mellitus (T2DM) and its complications, providing a robust meta-regression framework for selecting appropriate HSUV estimates. Method: We conducted a systematic review to extract HSUVs for T2DM and its complications, encompassing various influencing factors. Relevant literature was sourced from a review spanning 2000-2020, supplemented by literature from PubMed, Embase, and the Web of Science (up to March 2024). Multivariate meta-regression was performed to evaluate the impact of measurement tools, tariffs, health status, and clinical and demographic variables on HSUVs. Results: Our search yielded 118 studies, contributing 1044 HSUVs. The HSUVs for T2DM with complications varied, from 0.65 for cerebrovascular disease to 0.77 for neuropathy. The EQ-5D-3L emerged as the most frequently employed valuation method. HSUV differences across instruments were observed; 15-D had the highest (0.89), while HUI-3 had the lowest (0.70) values. Regression analysis elucidated the significant effects of instrument and tariff choice on HSUVs. Complication-related utility decrement, especially in diabetic foot, was quantified. Age <70 was linked to increased HSUVs, while longer illness duration, hypertension, overweight and obesity correlated with reduced HSUVs. Conclusion: Accurate HSUVs are vital for the optimization of T2DM management strategies. This study provided a comprehensive data pool for HSUVs selection, and quantified the influence of various factors on HSUVs, informing analysts and policymakers in understanding the utility variations associated with T2DM and its complications.
- Subjects
TYPE 2 diabetes; DIABETIC foot; DIABETES; CEREBROVASCULAR disease; INDUSTRIAL efficiency
- Publication
Health & Quality of Life Outcomes, 2024, Vol 22, Issue 1, p1
- ISSN
1477-7525
- Publication type
Article
- DOI
10.1186/s12955-024-02288-1